Applying IBM Watson & other human machine interface technologies for solving neurological & other disease problems.-Mike Kuznetsov-06/16/2015 - 8:30am

Event Information
Event Topic: 
Applying IBM Watson & other human machine interface technologies for solving neurological & other disease problems.
Event Date: 
06/16/2015 - 8:30am
Event Location: 
Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
Speaker Information
Event Speaker: 
Mike Kuznetsov
Event Speaker Company: 
Event Speaker Bio: 

Mike Kuznetsov

Mike has 15 years of experience in managing software development projects and companies, including startups, small, mid and large ones, and is currently finalizing MBA at HULT International School of Business in San Francisco. Before that he worked at IBM developing its Big Data portfolio business, and now is working on IBM Watson future applications in Healthcare industry as a part of his MBA consulting project.
Mike has MS in Mathematics, Physics and Computer Science from Moscow Institute of Physics and Technology (MIPT), Assistant Professor of Computer Science Chair where he taught for four years; and MBA from Moscow Institute of Business & Economy.

Event Details
Event Details: 

The cognitive damage caused by brain diseases and injuries such as Alzheimer’s, Parkinson’s and Traumatic Brain Injury, cripples individual lives and has a significant negative impact on society as a whole. This presentation will discuss the work of the Cognitive Computing and Artificial Intelligence industry in developing Human-Machine-Interface devices to address this problem, and also the results of some recent IBM Watson applications and case studies. While still early in development, these technologies already allow us to tackle some real clinical problems, such as human cognitive disability.

The presentation will cover:
1) overview of brain-related diseases impact on society
2) list of recent IBM Watson applications and case studies
3) review of HMI-related companies, technologies and researches in process
4) discussion of potential application of these technologies to augment human cognitive capabilities